Laidlaw Scholars Ventures
www.laidlawscholarsventures.comLaidlaw Scholars Ventures (LSV) is a for-profit initiative investing in start-ups founded and run by Laidlaw Scholars. Backed by $50m, LSV accelerates Good Businesses by financing growth, providing support services, delivering extensive training and development, and bringing a network of expert advisors and mentors to guide portfolio businesses. All profits from LSV will be returned to the Laidlaw Foundation to invest in its educational programmes designed to break the cycle of poverty, reduce inequality and develop a new generation of ethical leaders. Our portfolio includes: • Sable is a digital bank that allows marginalized Americans and new immigrants without a U.S. financial history to open accounts and build their credit scores quickly. • Sool is a drinks company that introduces traditional Korean alcohols with a modern twist to US and Asian audiences. • CardiaTec is a drug discovery company that leverages AI and large-scale multiomic data to identify novel targets for cardiovascular disease.
Read moreLaidlaw Scholars Ventures (LSV) is a for-profit initiative investing in start-ups founded and run by Laidlaw Scholars. Backed by $50m, LSV accelerates Good Businesses by financing growth, providing support services, delivering extensive training and development, and bringing a network of expert advisors and mentors to guide portfolio businesses. All profits from LSV will be returned to the Laidlaw Foundation to invest in its educational programmes designed to break the cycle of poverty, reduce inequality and develop a new generation of ethical leaders. Our portfolio includes: • Sable is a digital bank that allows marginalized Americans and new immigrants without a U.S. financial history to open accounts and build their credit scores quickly. • Sool is a drinks company that introduces traditional Korean alcohols with a modern twist to US and Asian audiences. • CardiaTec is a drug discovery company that leverages AI and large-scale multiomic data to identify novel targets for cardiovascular disease.
Read moreCountry
City (Headquarters)
London
Employees
1-10
Founded
2021
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(10)